HIV Levels Before Treatment Can Predict This Immune System Indicator

Researchers may have finally answered a bedeviling chicken-or-egg question about the relationship between the persistence of HIV in the body during antiretroviral (ARV) treatment and the virus-related immune system activation and inflammation that also continues while people are on ARVs. This finding likely adds further weight to the urgency of diagnosing and treating HIV as…

Continue reading →

Australia has been invited to participate in a global survey of the needs of PLHIV and we are nearly halfway to target!

We have until the end of the month to recruit another 75 Australian participants.  The study has been commissioned by an independent, global specialist HIV company with commitment to deliver innovative new options for the care and treatment of people living with HIV/AIDS. They have partnered with an independent market research agency in order to…

Continue reading →